Bell's Palsy Treatment Market size is estimated to reach USD 4.1 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of bell's palsy treatment was USD 2.5 Billion. The market growth can be credited to the rising prevalence of viral infections, such as chickenpox, rubella, herpes, and others, which are the primary cause of Bell’s palsy. According to the data from the U.S. National Library of Medicine, around 23 of every 100,000 people are affected by Bell’s palsy per year across the globe. Targeting the viral infection is the most common treatment method adopted by doctors. The increasing cases of viral diseases that reduce or compromise the immunity of patients are estimated to boost the market growth.
In addition to these, other factors that are believed to fuel the bell's palsy treatment market growth of Bell’s palsy include the increasing rate of diabetes. swollen up. Moreover, research has shown that diabetic patient exhibits higher susceptibility to facial nerve inflammation than compared to non-diabetic persons. As of 2023, according to the Diabetes Atlas around 537 million adults are living with diabetes.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~5% |
|
Base Year Market Size (2023) |
~ USD 2.5 Billion |
|
Forecast Year Market Size (2036) |
~ USD 4.1 Billion |
|
Regional Scope |
|
Medication (Corticosteroids, Antiviral Drugs), Physical Therapy, Surgery}
The medication segment in the bell's palsy treatment market is estimated to gain the largest revenue share of about 45% by 2036. The segment growth can be attributed to exploration of novel antiviral medications and corticosteroids which may lead to the introduction of more effective drugs. Currently, Corticosteroids are known to have anti-inflammatory properties which reduce the inflammation of the facial nerve. In a randomized controlled trial the recovery rate at nine months with prednisolone, a corticosteroid was 94%. It was 81.6% in patients who did not receive prednisolone.
End-User (Hospital, Specialty Clinics)
The bell's palsy treatment market is divided by end-user into hospital and specialty centers, with hospital being the top revenue generator, estimated to hold 62% of the share in the end-user segment. Hospitals stand out as the primary end users in the market, providing diagnostic support, therapy, and post-treatment care for individuals affected by Bell’s palsy. Within these hospitals, specialized divisions like neurology or otolaryngology house medical experts well-versed in diagnosing and treating Bell’s palsy, ensuring accessibility to specialized care for those in need.
Our in-depth analysis of the global bell’s palsy treatment market includes the following segments:
|
Diagnosis |
|
|
Treatment |
|
|
End-User |
|
North American Market Forecast
The bell's palsy treatment market in the North America region is anticipated to gain the largest revenue share of 29% during the forecast period on account of high healthcare expenditure, and the presence of major pharmaceutical companies. According to the Centers for Medicare and Medical Services, in 2022 United States of America spent USD 13,493 for the healthcare of every individual. The U.S. healthcare spending grew 4.1 percent in 2022, reaching 4.5 trillion USD. The North America region market is anticipated to lead the bell's palsy treatment market, with the onset of Bell’s palsy potentially accelerated by an increase in heart rate. Moreover, heightened government support, a growing demand for advanced technological therapies, and an increasing preference for minimally invasive procedures are anticipated to propel the growth of the market in North America.
APAC Market Analysis
The Asia Pacific bell's palsy treatment market is estimated to the second largest, share of about 22% by the end of 2036. The market’s expansion can be attributed majorly to the emerging healthcare infrastructure and improved medical facilities available in developing nations such as India, Bangladesh, and Indonesia. Moreover, a lack of sanitation and health awareness can be a cause of viral infection in the region. Furthermore, medical advancements in the region have profoundly grown over the years. For instance, from May 2021 to April 2023 a randomized controlled trial using Laser acupuncture and photobiomodulation was performed on patients who had Bell’s palsy for more than 8 weeks in the out-patient department of Otorhinolaryngology in Beijing Tongren Hospital, China. One group received laser acupuncture treatment and the control group received treatment without laser acupuncture 3 times per week. The study indicated that laser acupuncture was effective in Bell’s palsy patients rather than the control group.
21 July, 2020: Surgeons at UT Southwestern have developed a cutting-edge technique for Bell’s Palsy patients, enabling effective eye closure and corneal protection. Detailed in a 2020 journal article, the procedure involves a sophisticated approach that reinnervates eye muscles, ensuring faster and more complete closure. It’s most beneficial for patients with paralysis for under 18 months. The research conducted by UT Southwestern team has demonstrated that patients undergoing this procedure experience faster and more complete eye closure, leading to enhanced protection of the cornea. This innovation represents a significant advancement in Bell’s palsy treatment, underscoring UT Southwestern’s commitment to pioneering research and clinical excellence in reconstructive surgery.
April 27, 2023: Research in JAMA Otolaryngology – Head and Neck surgery compared Bell’s palsy incidence in Cvoid-19 vaccine recipients to unvaccinated or placebo groups. While incidence was higher among vaccinated individuals in randomized trails, no association was found in observational studies. Additionally, bell’s palsy was more common during CVOID-19infecion than after vaccination, with significant increase in risk compared to SARS-CoV-2 vaccines. Furthermore, more research is required to verify the results so far and also understand why some individuals develop Bell’s palsy after vaccination.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?